The email landed in my inbox at 2:47 AM. A reader I'll call "Diane from Ohio" forwarded a corporate recall notice with a single line: "Why isn't this on the news?"
She was talking about Intercon Chemical Company's hand soap recall — a voluntary pull of foaming hand soaps distributed to hospitals, schools, and government buildings across the country. The stated reason: bacterial contamination. Burkholderia cepacia, to be exact. A pathogen that's harmless to most healthy people but can be devastating for the immunocompromised, the elderly, and anyone with cystic fibrosis.
Here's where the dots start connecting.
Burkholderia cepacia isn't a random contaminant. It thrives in water-based products — soaps, mouthwashes, IV solutions. It's also notoriously resistant to common preservatives. So when it shows up in a product meant for *washing hands*, the question isn't just "how did it get there?" It's "how long was it there before anyone noticed?"
The recall notice itself is notably vague. No specific lot numbers published in the initial announcement. No distribution map. No list of the hospitals, nursing homes, or federal facilities that received the product. Just a sterile corporate statement and a promise to "cooperate fully with regulators."
Sound familiar? It should. This is the same playbook we saw with the 2023 eye drop recalls, the 2022 infant formula crisis, and the ongoing cinnamon applesauce lead situation. A quiet corporate notice, a delayed FDA acknowledgment, and a public that finds out months later — if at all.
But here's the angle the mainstream won't touch.
Intercon Chemical isn't a fly-by-night operation. They're a government contractor. Their hand soaps have been used in VA hospitals, military bases, and federal buildings. That means this recall touches the same supply chain that was already under scrutiny during COVID for shortages and quality control failures.
And Burkholderia cepacia? It's been on the CDC's radar for years as a healthcare-associated infection. In 2021, a similar contamination in a different brand of hand soap led to an outbreak in a neonatal ICU. The pattern isn't new. The response is.
Why does a voluntary recall get announced on a Friday afternoon? Why do the affected lot numbers take weeks to surface? Why are nursing homes — where residents are most vulnerable — often the last to know?
I reached out to Intercon Chemical for comment. Their spokesperson said the recall was "conducted in full coordination with the FDA" and that "consumer safety is our top priority." Standard language. But they wouldn't answer when I asked how many units were distributed, how many facilities were affected, or when the contamination was first detected.
The FDA's own recall database shows the entry — but it's buried, categorized as "ongoing," with no enforcement date listed. That's bureaucratic speak for "we're handling it internally."
Meanwhile, Diane from Ohio is still waiting for answers. She works at a nursing home. Her facility received a case of the recalled soap three weeks before the notice went out. They'd been using it the entire time.
This is the part where you're supposed to trust the system. Trust that voluntary recalls work. Trust that regulators are on top of it. Trust that the next contaminated product won't end up in your mother's hospital room or your kid's school bathroom.
But trust isn't a safety protocol. Transparency is. And right now, the Intercon recall is a masterclass in how to bury a public health story in plain sight.
**The takeaway:** A voluntary recall is still a recall. The difference between a "minor contamination event" and an outbreak is often just time and information — two things the public rarely gets in full. If your workplace or loved one's care facility uses foaming hand soap, ask where it came from. The label might say "antibacterial." It doesn't say "trust us."